Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth
2019
Post-translational modification of
chemokinesmediated by the
dipeptidyl peptidaseDPP4 (CD26) has been shown to negatively regulate lymphocyte trafficking, and its inhibition enhances T cell migration and tumor immunity by preserving functional
chemokine
CXCL10. By extending those initial findings to pre-clinical models of hepatocellular carcinoma and breast cancer, we discovered a distinct mechanism by which inhibition of DPP4 improves anti-tumor responses. Administration of the DPP4 inhibitor
sitagliptinresulted in higher concentrations of the
chemokine
CCL11and increased migration of
eosinophilsinto solid tumors. Enhanced tumor control was preserved in mice lacking lymphocytes and was ablated after depletion of
eosinophilsor treatment with
degranulationinhibitors. We further demonstrated that tumor-cell expression of the alarmin IL-33 was necessary and sufficient for
eosinophil-mediated anti-tumor responses and that this mechanism contributed to the efficacy of checkpoint-inhibitor therapy. These findings provide insight into IL-33- and
eosinophil-mediated tumor control, revealed when endogenous mechanisms of DPP4 immunoregulation are inhibited.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
48
References
62
Citations
NaN
KQI